Torge Rempe

608 total citations
29 papers, 409 citations indexed

About

Torge Rempe is a scholar working on Neurology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Torge Rempe has authored 29 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 13 papers in Pathology and Forensic Medicine and 9 papers in Oncology. Recurrent topics in Torge Rempe's work include Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (8 papers) and Polyomavirus and related diseases (8 papers). Torge Rempe is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Peripheral Neuropathies and Disorders (8 papers) and Polyomavirus and related diseases (8 papers). Torge Rempe collaborates with scholars based in United States, Germany and Canada. Torge Rempe's co-authors include Jennifer Graves, Ralf Baron, Olav Jansen, Jennifer H. Yang, Janne Gierthmühlen, Anastasie Dunn‐Pirio, Natalie Whitmire, Frank Leypoldt, Günther Deuschl and Thorsten Bartsch and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Torge Rempe

23 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torge Rempe United States 10 158 130 100 83 54 29 409
Dominic T. Schomberg United States 12 103 0.7× 67 0.5× 128 1.3× 19 0.2× 37 0.7× 18 497
Kerstin Schwenker Austria 12 170 1.1× 70 0.5× 68 0.7× 40 0.5× 23 0.4× 24 429
Miles Day United States 11 152 1.0× 56 0.4× 141 1.4× 16 0.2× 109 2.0× 30 537
Hatem Shehata Egypt 11 220 1.4× 149 1.1× 76 0.8× 25 0.3× 7 0.1× 35 361
David A. Stidd United States 12 76 0.5× 133 1.0× 43 0.4× 5 0.1× 26 0.5× 19 343
Shengjun Sun China 7 29 0.2× 77 0.6× 171 1.7× 13 0.2× 80 1.5× 18 470
Mostafa M. Ahmed United States 10 77 0.5× 25 0.2× 139 1.4× 51 0.6× 46 0.9× 29 392
Ye Tu China 12 42 0.3× 40 0.3× 36 0.4× 26 0.3× 12 0.2× 35 290
Laura Turpín‐Fenoll Spain 13 94 0.6× 138 1.1× 22 0.2× 38 0.5× 8 0.1× 26 424
Surajit Basu United Kingdom 13 28 0.2× 68 0.5× 23 0.2× 9 0.1× 81 1.5× 33 349

Countries citing papers authored by Torge Rempe

Since Specialization
Citations

This map shows the geographic impact of Torge Rempe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torge Rempe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torge Rempe more than expected).

Fields of papers citing papers by Torge Rempe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torge Rempe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torge Rempe. The network helps show where Torge Rempe may publish in the future.

Co-authorship network of co-authors of Torge Rempe

This figure shows the co-authorship network connecting the top 25 collaborators of Torge Rempe. A scholar is included among the top collaborators of Torge Rempe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torge Rempe. Torge Rempe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rees, John, et al.. (2025). Baló’s concentric sclerosis: A retrospective case series. Multiple Sclerosis and Related Disorders. 103. 106712–106712.
2.
Nguyen, Phuong, Torge Rempe, & Reza Forghani. (2024). Multiple Sclerosis. Magnetic Resonance Imaging Clinics of North America. 32(2). 363–374.
3.
Rempe, Torge, et al.. (2024). Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD). Multiple Sclerosis and Related Disorders. 87. 105672–105672. 2 indexed citations
4.
Rees, John, et al.. (2024). Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Magnetic Resonance Imaging Clinics of North America. 32(2). 233–251. 4 indexed citations
5.
Rempe, Torge, Alison Christy, Fernando X. Cuascut, et al.. (2024). Increased Intracranial Pressure in Myelin-Oligodendrocyte Glycoprotein Antibody–Associated Disease. The Neurologist. 30(1). 17–22.
6.
Rempe, Torge, et al.. (2023). Ocrelizumab B-cell repopulation-guided extended interval dosing versus standard dosing – similar clinical efficacy with decreased immunoglobulin M deficiency rates. Multiple Sclerosis and Related Disorders. 79. 105028–105028. 15 indexed citations
7.
Rempe, Torge, Jennifer H. Yang, Amanda Gooding, et al.. (2022). Longitudinal evaluation of neurologic‐post acute sequelae SARS‐CoV‐2 infection symptoms. Annals of Clinical and Translational Neurology. 9(7). 995–1010. 33 indexed citations
8.
Yang, Jennifer H., Torge Rempe, Natalie Whitmire, Anastasie Dunn‐Pirio, & Jennifer Graves. (2022). Therapeutic Advances in Multiple Sclerosis. Frontiers in Neurology. 13. 824926–824926. 80 indexed citations
9.
Rempe, Torge, et al.. (2022). Idiopathic relapsing neutrophilic meningoencephalitis – a case series. 2. 100153–100153.
10.
Rempe, Torge, et al.. (2021). Quantification of smooth pursuit dysfunction in multiple sclerosis. Multiple Sclerosis and Related Disorders. 54. 103073–103073. 5 indexed citations
11.
Rempe, Torge, et al.. (2021). CNS Lymphocytic Vasculitis in a Young Woman With COVID-19 Infection. Neurology Neuroimmunology & Neuroinflammation. 8(5). 16 indexed citations
12.
Rempe, Torge, et al.. (2020). Anti-MOG associated disorder–Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD–A single-center experience. Multiple Sclerosis and Related Disorders. 48. 102718–102718. 34 indexed citations
13.
Rempe, Torge, et al.. (2020). Anti-JCV antibody index does not change during ocrelizumab-treatment. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(3). 2455380478–2455380478. 4 indexed citations
14.
Rempe, Torge & S. H. Subramony. (2020). “Status myotonicus” in Nav1.4-M1592V channelopathy. Neuromuscular Disorders. 30(5). 424–426. 1 indexed citations
15.
Rempe, Torge, et al.. (2020). Corticosteroids lead to short-term improvement in cerebral amyloid angiopathy-related inflammation. Journal of Neuroimmunology. 348. 577377–577377. 7 indexed citations
16.
Ho, Kwo Wei David, Torge Rempe, Nivedita U. Jerath, & Ajay Antony. (2019). Dorsal Root Ganglion Stimulation as a Potentially Effective Treatment for Painful Hereditary and Idiopathic Axonal Polyneuropathy: A Retrospective Case Series. Neuromodulation Technology at the Neural Interface. 23(2). 234–238. 5 indexed citations
17.
Rempe, Torge, Jos Becktepe, Imke Metz, et al.. (2019). A case of CLIPPERS syndrome responsive to tocilizumab. Neurology Neuroimmunology & Neuroinflammation. 6(3). e545–e545. 8 indexed citations
18.
Reimer, Maren, et al.. (2016). Sensitization of the Nociceptive System in Complex Regional Pain Syndrome. PLoS ONE. 11(5). e0154553–e0154553. 40 indexed citations
19.
Bartsch, Thorsten, Torge Rempe, Arne Wrede, et al.. (2015). Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate. Annals of Neurology. 78(4). 501–514. 40 indexed citations
20.
Rempe, Torge, Stephan Wolff, Christian Riedel, et al.. (2014). Spinal fMRI Reveals Decreased Descending Inhibition during Secondary Mechanical Hyperalgesia. PLoS ONE. 9(11). e112325–e112325. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominic T. Schomberg Breakdown of academic impact, for papers by Kerstin Schwenker Breakdown of academic impact, for papers by Miles Day Breakdown of academic impact, for papers by Hatem Shehata Breakdown of academic impact, for papers by David A. Stidd Breakdown of academic impact, for papers by Shengjun Sun Breakdown of academic impact, for papers by Mostafa M. Ahmed Breakdown of academic impact, for papers by Ye Tu Breakdown of academic impact, for papers by Laura Turpín‐Fenoll Breakdown of academic impact, for papers by Surajit Basu
Rankless by CCL
2026